This is a preview of subscription content, log in via an institution to check access.
Reference
Bichoupan K, et al. Costs of Telaprevir-based Triple Therapy for Hepatitis C: $189,000 per Sustained Virologic Response. Hepatology : 28 Jul 2014. Available from: URL: http://doi.org/10.1002/hep.27340
Rights and permissions
About this article
Cite this article
Telaprevir-based tx less effective, more costly than projected. PharmacoEcon Outcomes News 709, 9 (2014). https://doi.org/10.1007/s40274-014-1466-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1466-y